Toward Greater Diversity in Psychedelic Science.
Psychiatric services (Washington, D.C.) February 5, 2026 DOI: 10.1176/appi.ps.20250169 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Cultural competence Drug treatment/psychopharmacology Psychedelics Racial-ethnic disparities Racism |
| Citations | 1 |
| Key findings | Racial-ethnic diversity is lacking in psychedelic science and efforts to increase representation remain insufficient. |
Abstract
Racial-ethnic diversity is lacking in psychedelic science. Efforts have been made to increase racial-ethnic representation among clinical trial participant populations, but much work remains. This column aims to describe this disparity, outline potential benefits of eliminating this disparity, and provide recommendations for achieving equity and justice within the research landscape of psychedelic treatments for mental disorders.